This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
11-13 November 2025
Congress Center BaselBasel, Switzerland

Letizia Volpe, Ph.D.
Site MS&T Head Chemical Operations at Novartis
Speaker

Profile

Letizia Volpe, born in Italy, after her studies in Chemical Engineering in Padua, Italy and her PhD in Process Engineering in Hannover, Germany, has assumed several roles in the specialty chemicals and pharmaceutical industry in Switzerland in both development and chemical/ API manufacturing. Since 2013 in Novartis, she has assumed the role of Manufacturing Science and Technology Head Chemical Operations Switzerland back in 2020. In the same year she embarked in the oligonucleotides journey taking over also the responsibility of leading the technical transfer of Leqvio drug substance to the Swiss site of Schweizerhalle.

Agenda Sessions

  • Plant Design and Manufacturing Challenges with Insights from Leqvio

    10:15
  • Process Development & Manufacturing of Oligos

    11:15